Skip to content

Free cash flow at other companies

Abbott logo
AbbottABT
$916M-1.8%
TFX
TeleflexTFX
$27.87M+676%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$816M+126%
Danaher logo
DanaherDHR
$1.09B+2.9%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST

Other financials

Income statement

See full
Revenue$4.7B+5.2%
Gross profit$2.2B+15.7%
Operating income$93.0M-75.7%
Net income-$311.0M-201%
EPS (diluted)-$1.11-204%

Balance sheet

See full
Cash & equivalents$1.0B+49.0%
Total debt$14.7B-16.8%
Total equity$24.1B-4.4%
Total assets$50.8B-6.7%

Cash flow

See full
Operating cash flow$671.0M
CapEx$125.0M+9.6%

Valuation

See full
Market cap$42.96B-12.6%
Enterprise value$56.65B-14.0%
P/E37.8×+6.7×
P/S-0.4×

Profitability

See full
Gross margin46.8%+2.5pp
Operating margin10.4%+0.1pp
Net margin5.3%-2.1pp
FCF margin16.4%

Returns & leverage

See full
Return on equity4.6%-1.3pp
Debt / equity0.6×-0.1×
Current ratio0.9×-0.2×

Where this comes from

Calculated from Becton, Dickinson and Company’s reported figures.

The official record: Becton, Dickinson and Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Becton, Dickinson and Company's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Becton, Dickinson and Company's free cash flow?
Becton, Dickinson and Company (BDX) reported free cash flow of $546M in Q1 2026.
What is the long-term trend for Becton, Dickinson and Company's free cash flow?
Over 3 years (2021 to 2024), Becton, Dickinson and Company's free cash flow has grown at a -3.3% compound annual growth rate (CAGR), from $3.45B to $3.12B.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.